{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T05:03:47Z","timestamp":1784610227505,"version":"3.55.0"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Glaucoma and Alzheimer's disease (AD) are major neurodegenerative disorders with increasing evidence of shared pathogenic pathways. Glaucoma involves progressive optic nerve degeneration and irreversible vision loss, often associated with elevated intraocular pressure (IOP) but also occurring independently of it. AD, the leading cause of dementia, results in progressive cognitive and functional decline, with vision disturbances including visual field defects. Epidemiological studies report higher co-prevalence of glaucoma and AD in older adults. This study longitudinally assessed IOP in a transgenic AD mouse model to determine whether AD-related amyloid pathology inherently drives alterations in ocular pressure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Ten young (25 weeks old; 9 males, 1 female) and fifteen aged 5xFAD (57\u201360 weeks old; 5 males and 10 females) transgenic mice, a well-established amyloidogenic model of AD, were examined. Age-matched control groups included ten young wild type (WT) mice (9 males and 1 female) and fourteen aged WT mice (7 males and 7 females). IOP was measured repeatedly without anesthesia using a rebound tonometer (Icare Tonolab) calibrated for mice. Four IOP measurement sessions were performed at days 1, 36, 55, and 77, with all measurements conducted during midday hours (11:00\u201314:00) to minimize circadian variability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>IOP remained stable across most groups and time points. Aged 5xFAD mice exhibited transient, statistically significant fluctuations, characterized by an initial decrease at day 36 followed by a return to baseline levels. Age-matched WT mice showed no significant longitudinal changes. When comparing between groups, the only significant difference was observed at day 36, where aged 5xFAD mice demonstrated significantly lower IOP than aged WT controls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>5xFAD mice did not exhibit sustained IOP elevation compared with WT controls, with aged animals displaying only transient fluctuations that likely reflect physiological or measurement variability. These results suggest that amyloid-driven pathology in this model is not accompanied by chronic ocular hypertension. Consequently, our findings support the hypothesis that visual dysfunction in AD models may occur independently of elevated intraocular pressure, though the specific overlapping mechanisms between AD and glaucoma warrant cautious interpretation and further investigation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneur.2026.1858031","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T04:19:30Z","timestamp":1784607570000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Longitudinal assessment of intraocular pressure in the 5xFAD mouse model of Alzheimer's disease"],"prefix":"10.3389","volume":"17","author":[{"given":"Raz","family":"Rubinshtein","sequence":"first","affiliation":[{"name":"Ophthalmology Department, The Krieger Eye Research Laboratory, Bruce and Ruth Faculty of Medicine, Technion-Institute of Technology","place":["Haifa, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basel","family":"Obied","sequence":"additional","affiliation":[{"name":"Ophthalmology Department, The Krieger Eye Research Laboratory, Bruce and Ruth Faculty of Medicine, Technion-Institute of Technology","place":["Haifa, Israel"]},{"name":"Department of Ophthalmology, Bnai-Zion Medical Center","place":["Haifa, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talal","family":"Salti","sequence":"additional","affiliation":[{"name":"Ophthalmology Department, The Krieger Eye Research Laboratory, Bruce and Ruth Faculty of Medicine, Technion-Institute of Technology","place":["Haifa, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres I.","family":"K\u00f6nig","sequence":"additional","affiliation":[{"name":"Ophthalmology Department, School of Neurobiology, Biochemistry and Biophysics, Tel-Aviv University","place":["Tel Aviv, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alon","family":"Zahavi","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Laboratory of Eye Research, Rabin Medical Center","place":["Petach Tikva, Israel"]},{"name":"Ophthalmology Department, Gray Faculty of Medical and Health Sciences, Tel Aviv University","place":["Tel Aviv, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitza","family":"Goldenberg-Cohen","sequence":"additional","affiliation":[{"name":"Ophthalmology Department, The Krieger Eye Research Laboratory, Bruce and Ruth Faculty of Medicine, Technion-Institute of Technology","place":["Haifa, Israel"]},{"name":"Department of Ophthalmology, Bnai-Zion Medical Center","place":["Haifa, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3708","DOI":"10.1002\/alz.13809","volume":"20","year":"2024","journal-title":"Alzheimers Dement"},{"key":"B2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ibneur.2023.11.003","article-title":"Current biomarkers and treatment strategies in Alzheimer disease: an overview and future perspectives","volume":"16","author":"Bhole","year":"2024","journal-title":"IBRO Neurosci Rep."},{"key":"B3","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1167\/iovs.13-12888","article-title":"Ocular changes in TGF344-AD rat model of Alzheimer's disease","volume":"55","author":"Tsai","year":"2014","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B4","first-page":"64","article-title":"The optic neuropathy of Alzheimer's disease","volume":"12","author":"Sadun","year":"1989","journal-title":"Metab Pediatr Syst Ophthalmol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/WNO.0b013e31821b602c","article-title":"Low-density lipoprotein receptor-related protein is decreased in optic neuropathy of Alzheimer disease","volume":"31","author":"Cuzzo","year":"2011","journal-title":"J Neuroophthalmol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1159\/000464422","article-title":"Molecular pathogenesis of alzheimer's disease: an update","volume":"24","author":"Sanabria-Castro","year":"2017","journal-title":"Ann Neurosci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.ophtha.2025.06.002","article-title":"Prevalence of glaucoma in Europe and projections to 2050: findings from the European eye epidemiology consortium","volume":"132","author":"Stuart","year":"2025","journal-title":"Ophthalmology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2147\/EB.S293765","article-title":"Glaucoma as neurodegeneration in the brain","volume":"13","author":"Chan","year":"2021","journal-title":"Eye Brain."},{"key":"B9","doi-asserted-by":"publisher","first-page":"4581","DOI":"10.1002\/hbm.23330","article-title":"Early changes of brain connectivity in primary open angle glaucoma","volume":"37","author":"Frezzotti","year":"2016","journal-title":"Hum Brain Mapp."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e105931","DOI":"10.1371\/journal.pone.0105931","article-title":"Structural and functional brain changes beyond visual system in patients with advanced glaucoma","volume":"9","author":"Frezzotti","year":"2014","journal-title":"PLoS One."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2651645","DOI":"10.1155\/2017\/2651645","article-title":"Long-term clinical course of normal-tension glaucoma: 20 years of experience","volume":"2017","author":"Jin","year":"2017","journal-title":"J Ophthalmol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"9329310","DOI":"10.1155\/2020\/9329310","article-title":"Innovative IOP-Independent neuroprotection and neuroregeneration strategies in the pipeline for glaucoma","volume":"2020","author":"Tsai","year":"2020","journal-title":"J Ophthalmol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1111\/j.1755-3768.2011.02125.x","article-title":"Normal tension glaucoma and Alzheimer disease: comorbidity?","volume":"90","author":"Bach-Holm","year":"2012","journal-title":"Acta Ophthalmol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"971","DOI":"10.2174\/1570159X16666171206144045","article-title":"Glaucoma and Alzheimer disease: one age-related neurodegenerative disease of the brain","volume":"16","author":"Mancino","year":"2017","journal-title":"Curr Neuropharmacol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"6900","DOI":"10.3390\/jcm12216900","article-title":"Glaucoma as a tauopathy\u2014is it the missing piece in the glaucoma puzzle?","volume":"12","author":"Passaro","year":"2023","journal-title":"J Clin Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/IJG.0b013e31802b3527","article-title":"No increased risk of developing Alzheimer disease in patients with glaucoma","volume":"16","author":"Kessing","year":"2007","journal-title":"J Glaucoma."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/j.immuni.2022.07.014","article-title":"Apolipoprotein E4 impairs the response of neurodegenerative retinal microglia and prevents neuronal loss in glaucoma","volume":"55","author":"Margeta","year":"2022","journal-title":"Immunity"},{"key":"B18","doi-asserted-by":"publisher","first-page":"6766","DOI":"10.3390\/ijms25126766","article-title":"Behaviour hallmarks in Alzheimer's disease 5xFAD mouse model","volume":"25","author":"P\u00e1dua","year":"2024","journal-title":"Int J Mol Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41597-021-01054-y","article-title":"Systematic phenotyping and characterization of the 5xFAD mouse model of Alzheimer's disease","volume":"8","author":"Forner","year":"2021","journal-title":"Sci Data."},{"key":"B20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13024-024-00712-0","article-title":"Updates on mouse models of Alzheimer's disease","volume":"19","author":"Zhong","year":"2024","journal-title":"Mol Neurodegener."},{"key":"B21","doi-asserted-by":"publisher","first-page":"713726","DOI":"10.3389\/fnagi.2021.713726","article-title":"Comprehensive evaluation of the 5XFAD mouse model for preclinical testing applications: a MODEL-AD study","volume":"13","author":"Oblak","year":"2021","journal-title":"Front Aging Neurosci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"862","DOI":"10.3389\/fnins.2020.00862","article-title":"Retinal functional and structural changes in the 5xFAD mouse model of Alzheimer's disease","volume":"14","author":"Lim","year":"2020","journal-title":"Front Neurosci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e0319397","DOI":"10.1371\/journal.pone.0319397","article-title":"Retinal and thalamic alterations in the 5xFAD mouse model of Alzheimer's disease","volume":"20","author":"McCool","year":"2025","journal-title":"PLoS One."},{"key":"B24","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s13195-025-01784-w","article-title":"A longitudinal study of the 5xFAD mouse retina delineates Amyloid beta (A\u03b2)-mediated retinal pathology from age-related changes","volume":"17","author":"Lynn","year":"2025","journal-title":"Alzheimers Res Ther."},{"key":"B25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.54254\/2753-8818\/6\/20230126","article-title":"A review of current developments in Alzheimers disease treatment methods","volume":"6","author":"Xu","year":"2023","journal-title":"Theoret Nat Sci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1056\/NEJMoa2310168","article-title":"Biomarker changes during 20 years preceding Alzheimer's disease","volume":"390","author":"Jia","year":"2024","journal-title":"N Engl J Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"7290","DOI":"10.3390\/ijms21197290","article-title":"Retinal degeneration and Alzheimer's disease: an evolving link","volume":"21","author":"Ashok","year":"2020","journal-title":"Int J Mol Sci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.ophtha.2023.02.017","article-title":"Risk of dementia in newly diagnosed glaucoma","volume":"130","author":"Park","year":"2023","journal-title":"Ophthalmology."},{"key":"B29","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.ophtha.2023.10.014","article-title":"Risk of Alzheimer's disease and related dementias in persons with glaucoma","volume":"131","author":"Crump","year":"2024","journal-title":"Ophthalmology."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.jamda.2023.06.025","article-title":"The association between eye disease and incidence of dementia: systematic review and meta-analysis","volume":"24","author":"Feng","year":"2023","journal-title":"J Am Med Dir Assoc"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1038\/s41433-020-0836-x","article-title":"Neurodegeneration in Alzheimer's disease and glaucoma: overlaps and missing links","volume":"34","author":"Sen","year":"2020","journal-title":"Eye (Lond)."},{"key":"B32","doi-asserted-by":"publisher","first-page":"101273","DOI":"10.1016\/j.preteyeres.2024.101273","article-title":"Alzheimer's disease pathophysiology in the retina","volume":"101","author":"Gaire","year":"2024","journal-title":"Prog Retin Eye Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s00401-016-1613-6","article-title":"Ocular indicators of Alzheimer's: exploring disease in the retina","volume":"132","author":"Hart","year":"2016","journal-title":"Acta Neuropathol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"880576","DOI":"10.3389\/fnagi.2022.880576","article-title":"Shared genetic architecture between the two neurodegenerative diseases: Alzheimer's disease and glaucoma","volume":"14","author":"Zheng","year":"2022","journal-title":"Front Aging Neurosci."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/genes14020338","article-title":"Genetic factors implicated in the investigation of possible connections between Alzheimer's disease and primary open angle glaucoma","author":"Kuang","year":"2023","journal-title":"Genes (Basel.)"},{"key":"B36","doi-asserted-by":"publisher","first-page":"7290","DOI":"10.3390\/ijms21197290","article-title":"Retinal degeneration and Alzheimer's disease: an evolving link","volume":"21","author":"Ashok","year":"2020","journal-title":"Int J Mol Sci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e20240386","DOI":"10.1084\/jem.20240386","article-title":"Transport of \u03b2-amyloid from brain to eye causes retinal degeneration in Alzheimer's disease","volume":"221","author":"Cao","year":"2024","journal-title":"J Exp Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"14092","DOI":"10.3390\/ijms241814092","article-title":"The expression of major facilitator superfamily domain-containing Protein2a (Mfsd2a) and Aquaporin 4 is altered in the retinas of a 5xFAD mouse model of Alzheimer's disease","volume":"24","author":"Jovanovic Macura","year":"2023","journal-title":"Int J Mol Sci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e0272811","DOI":"10.1371\/journal.pone.0272811","article-title":"Glaucoma and Alzheimer: Neurodegenerative disorders show an adrenergic disbalance","volume":"17","author":"Hohberger","year":"2022","journal-title":"PLoS One."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.3390\/ijms23052486","article-title":"Alzheimer's disease seen through the eye: ocular alterations and neurodegeneration","volume":"23","author":"Romaus-Sanjurjo","year":"2022","journal-title":"Int J Mol Sci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1167\/iovs.66.3.34","article-title":"Three-dimensional \u03b2-amyloid burden correlation between the eye and brain in Alzheimer's disease mice using light-sheet fluorescence microscopy","volume":"66","author":"Son","year":"2025","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"42","DOI":"10.2174\/0115672050425207251129073017","article-title":"MicroRNA signatures in Alzheimer's disease and normal-tension glaucoma: a comparative expression analysis of miR-128 and miR-455-3p","author":"Arish","year":"2026","journal-title":"Curr Alzheimer Res"},{"key":"B43","doi-asserted-by":"publisher","first-page":"862","DOI":"10.3389\/fnins.2020.00862","article-title":"Retinal functional and structural changes in the 5xFAD mouse model of Alzheimer's disease","volume":"14","author":"Lim","year":"2020","journal-title":"Front Neurosci."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.3390\/cells11152413","article-title":"Retinal vascular physiology biomarkers in a 5XFAD mouse model of Alzheimer's disease","volume":"11","author":"Matei","year":"2022","journal-title":"Cells."},{"key":"B45","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3389\/fneur.2016.00055","article-title":"Visual and ocular manifestations of Alzheimer's disease and their use as biomarkers for diagnosis and progression","volume":"7","author":"Javaid","year":"2016","journal-title":"Front Neurol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1111\/opo.13550","article-title":"Visual field defects in dementia: a scoping review","volume":"45","author":"Phu","year":"2025","journal-title":"Ophthalmic Physiol Opt."},{"key":"B47","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3143\/geriatrics.31.388","volume":"31","author":"Hanyu","year":"1994","journal-title":"Nihon Ronen Igakkai Zasshi"},{"key":"B48","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3389\/fneur.2017.00389","article-title":"Visual dysfunction in posterior cortical atrophy","volume":"8","author":"Maia da Silva","year":"2017","journal-title":"Front Neurol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"108397","DOI":"10.1016\/j.visres.2024.108397","article-title":"A new mouse-fixation device for IOP measurement in awake mice","volume":"219","author":"Guo","year":"2024","journal-title":"Vision Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"5764","DOI":"10.1167\/iovs.15-16720","article-title":"Strain and age effects on aqueous humor dynamics in the mouse","volume":"56","author":"Millar","year":"2015","journal-title":"Invest Opthalmol Vis Sci."},{"key":"B51","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.exer.2012.04.006","article-title":"The effects of anesthesia, mouse strain and age on intraocular pressure and an improved murine model of experimental glaucoma","volume":"99","author":"Cone","year":"2012","journal-title":"Exp Eye Res."},{"key":"B52","doi-asserted-by":"publisher","first-page":"101021","DOI":"10.1016\/j.preteyeres.2021.101021","article-title":"Age and intraocular pressure in murine experimental glaucoma","volume":"88","author":"Di Pierdomenico","year":"2022","journal-title":"Prog Retin Eye Res."},{"key":"B53","first-page":"249","article-title":"Intraocular pressure in inbred mouse strains","volume":"38","author":"John","year":"1997","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B54","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1212\/WNL.45.1.68","article-title":"Visual field loss in senile dementia of the Alzheimer's type","volume":"45","author":"Trick","year":"1995","journal-title":"Neurology."},{"key":"B55","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3233\/JAD-2010-080785","article-title":"Visual impairment in Alzheimer's disease: A critical review","volume":"21","author":"Kirby","year":"2010","journal-title":"J Alzheimers Dis."},{"key":"B56","doi-asserted-by":"publisher","first-page":"5963","DOI":"10.3390\/jcm14175963","article-title":"Visual function in Alzheimer's disease: Current understanding and potential mechanisms behind visual impairment","volume":"14","author":"Alvite-Pi\u00f1eiro","year":"2025","journal-title":"J Clin Med"},{"key":"B57","doi-asserted-by":"publisher","first-page":"e668","DOI":"10.1111\/aos.13319","article-title":"Visual system manifestations of Alzheimer's disease","volume":"95","author":"Kusne","year":"2017","journal-title":"Acta Ophthalmol."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1858031\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T04:19:31Z","timestamp":1784607571000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1858031\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":57,"alternative-id":["10.3389\/fneur.2026.1858031"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2026.1858031","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"article-number":"1858031"}}